Arunjyothi Bio Ventures Limited (BOM:530881)
5.58
-0.12 (-2.11%)
At close: May 25, 2026
Arunjyothi Bio Ventures Revenue
In the fiscal year ending March 31, 2026, Arunjyothi Bio Ventures had annual revenue of 277.54M INR, down -0.47%. Arunjyothi Bio Ventures had revenue of 72.37M in the quarter ending March 31, 2026, with 37.04% growth.
Revenue
277.54M
Revenue Growth
-0.47%
P/S Ratio
3.75
Revenue / Employee
1.67M
Employees
166
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 277.54M | -1.30M | -0.47% |
| Mar 31, 2025 | 278.84M | 74.53M | 36.48% |
| Mar 31, 2024 | 204.32M | 186.96M | 1,077.40% |
| Mar 31, 2023 | 17.35M | -12.36M | -41.59% |
| Mar 31, 2022 | 29.71M | -25.42M | -46.11% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Optimus Finance | 1.73B |
| AG Ventures | 1.11B |
| Upsurge Investment & Finance | 899.10M |
| RSD Finance | 737.54M |
| Tilak Ventures | 265.97M |
| Bampsl Securities | 238.71M |
| HB Portfolio | 230.16M |
| Apollo Finvest (India) | 169.67M |